Shareholding disclosure
Novartis International AG
Declared position
5%
Threshold
Fell below threshold
Timeline
Published
22.01.2004
Transaction
—
Voting rights breakdown
Voting rights acquired0%
Voting rights sold0%
Below threshold5%
Notice details
CategoryGroup of shareholders
ExchangeXSWX
Notification ID
T2394D2366
Beneficial owner
Novartis International AG
Declared address
Novartis International AG, Basel
Die Beteiligung an der Cytos Biotechnology AG wurde bis anhin von Novartis Venture Fund gemanagt und wird auch weiterhin von Novartis Venture Fund gemanagt werden.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open